Skip to search formSkip to main contentSkip to account menu

atractylenolide I

Known as: 8,9-dehydroasterolide 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

LactonesSesquiterpenes

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Antitumor Activity of Atractylenolide II on Breast Cancer Cells through Regulation of Estrogen Receptor Protein Expression and NF-Kb Signaling Pathways
Many women in the world are suffering from breast cancer deeply. Although many efforts are made in the study of breast cancer… 
2016
2016
Strong Specific Inhibition of UDP‐glucuronosyltransferase 2B7 by Atractylenolide I and III
Drug‐metabolizing enzymes inhibition‐based drug–drug interaction remains to be the key limiting factor for the research and… 
2015
2015
ERK/GSK3β signaling is involved in atractylenolide I-induced apoptosis and cell cycle arrest in melanoma cells.
Novel agents need to be developed to overcome the limitations of the current melanoma therapeutics. Atractylenolide I (AT-I) is a… 
2012
2012
[Protective effect of atractylenolide I on immunological liver injury].
OBJECTIVE To study the protective effect of atractylenolide I on immunological liver injury induced by BCG and LPS. METHOD… 
2000
2000
Antagonistic effects of 3 sesquiterpene lactones from Atractylodes macrocephala Koidz on rat uterine contraction in vitro.
AIM To study the effects of three sesquiterpene lactones: atractylenolide I (8,9-dehydroasterolide, B), 4,15-epoxy-8 beta… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)